| Type | Mutations | Age | Aβ in retina | Aβ plaques | Aβ in retinal vasculature | APP immunoreactivity | Tau deposits | Neuroinflammation | Neuronal cell loss | References |
| Single |
APPswe double K595N/M596L | 14 months | GCL, IPL, INL, OPL, ONL | Yes | Retinal capillaries | GCL, INL | GCL, IPL, INL, OPL, ONL | Detected in all layers of retina | Yes | [105] |
| Single | APPswe double K595N/M596L | 14 months | GCL | No | n/a | GCL, INL | n/a | n/a | n/a | [106] |
| Single | APPswe double K595N/M596L | 24 months | GCL, INL, ONL | No | n/a | Yes—layers not specified | n/a | n/a | n/a | [109] |
| Single | PS1 knock-in | 12, 15 and 30 months | Not detected | No | n/a | Not detected | n/a | n/a | n/a | [109] |
| Single | Human P301S tau | 2–5 months | n/a | Yes | n/a | n/a | RNFL, GCL | n/a | No | [110] |
| Double | APPswe/PS1M146L | 7.8 months | Virtually absent | Yes | Not detected | GCL, INL | n/a | GCL (less than at 27 months) | GCL (less than at 27 months) | [107] |
| Double | APPswe/PS1M146L | 27 months | RNFL, GCL | Yes | Retinal and choroidal | GCL, IPL, INL, OPL, OS, RPE | n/a | GCL, IPL, OPL | GCL | [107] |
| Double | APPswe/PS1ΔE9 | 10.5 months | RNFL | Yes | Choroidal only | GCL | n/a | GCL, IPL | GCL | [107] |
| Double | APPswe/PS1ΔE9 | 9 months | GCL, IPL, INL, OPL | No | n/a | IPL, OPL | n/a | n/a | n/a | [106] |
| Double | APPswe/PS1ΔE9 | 12–21 months | IPL, OPL | IPL, OPL | n/a | n/a | n/a | n/a | No | [108] |
| Double | APPswe/PS1ΔE9 | 24 months | GCL, INL, ONL | No | n/a | Yes—layers not specified | n/a | n/a | n/a | [109] |
| Double | APPswe/PS1ΔE9 | 2.5–17 months | RNFL, GCL, IPL, INL, OPL, OS | RNFL, GCL, IPL, INL, OPL, OS | n/a | n/a | n/a | n/a | n/a | [69] |
| Triple | APPswe/PS1/P301L | 18 months | n/a | n/a | n/a | n/a | n/a | n/a | Yes | [45] |
| Triple | APPswe/PS1/P301L | 18 months | GCL, OS | GCL, OS | n/a | n/a | GCL, IPL, INL, OPL, ONL, OS | n/a | n/a | [111] |
|
|